Do sulfonylurea drugs increase the risk of cardiac events?
- PMID: 16415463
- PMCID: PMC1329456
- DOI: 10.1503/cmaj.051237
Do sulfonylurea drugs increase the risk of cardiac events?
Comment on
-
Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.CMAJ. 2006 Jan 17;174(2):169-74. doi: 10.1503/cmaj.050748. CMAJ. 2006. PMID: 16415461 Free PMC article.
Similar articles
-
Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality.J Diabetes Investig. 2016 Sep;7(5):674-6. doi: 10.1111/jdi.12494. Epub 2016 Mar 24. J Diabetes Investig. 2016. PMID: 27181105 Free PMC article.
-
Is it time to ban sulfonylureas?J Diabetes. 2020 Nov;12(11):848-850. doi: 10.1111/1753-0407.13095. Epub 2020 Aug 7. J Diabetes. 2020. PMID: 32767650 No abstract available.
-
Does mortality risk vary among sulfonylureas?Lancet Diabetes Endocrinol. 2015 Jan;3(1):6-7. doi: 10.1016/S2213-8587(14)70217-7. Epub 2014 Oct 22. Lancet Diabetes Endocrinol. 2015. PMID: 25466240 No abstract available.
-
Pharmacology of antihyperglycemic drugs.N Y State J Med. 1972 Sep 1;72(17):2174-8. N Y State J Med. 1972. PMID: 4560042 Review. No abstract available.
-
[Sulfonylurea drugs for type 2 diabetes].Nihon Rinsho. 2002 Sep;60 Suppl 9:339-45. Nihon Rinsho. 2002. PMID: 12387015 Review. Japanese. No abstract available.
Cited by
-
Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs.Cureus. 2023 Oct 2;15(10):e46373. doi: 10.7759/cureus.46373. eCollection 2023 Oct. Cureus. 2023. PMID: 37920618 Free PMC article. Review.
-
Use of Diabetes Medications before and after a Heart Failure-Related Hospitalization among Nursing Home Residents.J Am Med Dir Assoc. 2024 Mar;25(3):454-458. doi: 10.1016/j.jamda.2023.06.033. Epub 2023 Aug 5. J Am Med Dir Assoc. 2024. PMID: 37553080
-
Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus.Pharmaceuticals (Basel). 2021 Aug 17;14(8):806. doi: 10.3390/ph14080806. Pharmaceuticals (Basel). 2021. PMID: 34451903 Free PMC article. Review.
-
The Effect of an Aerobic Exercise Programme on Blood Glucose Level, Cardiovascular Parameters, Peripheral Oxygen Saturation, and Body Mass Index among Southern Nigerians with Type 2 Diabetes Mellitus, Undergoing Concurrent Sulfonylurea and Metformin Treatment.Malays J Med Sci. 2019 Sep;26(5):88-97. doi: 10.21315/mjms2019.26.5.8. Epub 2019 Nov 4. Malays J Med Sci. 2019. PMID: 31728121 Free PMC article.
-
Effect of glucose-lowering therapies on heart failure.Nat Rev Cardiol. 2018 May;15(5):282-291. doi: 10.1038/nrcardio.2017.211. Epub 2018 Jan 25. Nat Rev Cardiol. 2018. PMID: 29368701 Review.
References
-
- Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemic: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36. - PubMed
-
- Andreotti F, Pasceri V, Hackett DR, et al. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996;334:7-12. - PubMed
-
- Garratt KN, Brady PA, Hassinger NL, et al. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999;33:119-24. - PubMed
-
- Huizar JF, Gonzalez LA, Alderman J, et al. Sulfonylureas attenuate electrocardiographic ST-segment elevation during an acute myocardial infarction in diabetics. J Am Coll Cardiol 2003;42:1017-21. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical